We are live on ! Find out more
PAWC

P.A.W. Capital Portfolio holdings

AUM $131M
1-Year Est. Return 46.14%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+46.14%
3 Year Est. Return
+67.18%
5 Year Est. Return
+64.85%
10 Year Est. Return
+1,459.33%
AUM
$94.2M
AUM Growth
-$4.78M
Cap. Flow
-$11.6M
Cap. Flow %
-12.36%
Top 10 Hldgs %
40.89%
Holding
73
New
9
Increased
6
Reduced
17
Closed
7

Top Buys

Rank Stock Value
1
PVLA
Palvella Therapeutics
PVLA
+$1.36M
2
MGNI icon
Magnite
MGNI
+$1.06M
3
KRYS icon
Krystal Biotech
KRYS
+$503K
4
CUE icon
Cue Biopharma
CUE
+$482K
5
GAIA icon
Gaia
GAIA
+$359K

Top Sells

Rank Stock Value
1
SMLR
Semler Scientific
SMLR
+$1.69M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$1.13M
3
ATTU
Attunity Ltd
ATTU
+$1.02M
4
AKBA icon
Akebia Therapeutics
AKBA
+$998K
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$951K

Sector Composition

Rank Sector Weight
1 Technology 32.35%
2 Healthcare 15.54%
3 Communication Services 14.8%
4 Industrials 10.95%
5 Consumer Staples 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVX icon
51
Chevron
CVX
$392B
$611K 0.65%
5,000
– –
IBM icon
52
IBM
IBM
$211B
$605K 0.64%
4,184
– –
BX icon
53
Blackstone
BX
$102B
$571K 0.61%
15,000
– –
CG icon
54
Carlyle Group
CG
$16.6B
$564K 0.6%
25,000
– –
KHC icon
55
Kraft Heinz
KHC
$30.7B
$551K 0.59%
10,000
-1,000
-9% -$59.8K
CMCSA icon
56
Comcast
CMCSA
$85B
$531K 0.56%
15,000
– –
KRYS icon
57
Krystal Biotech
KRYS
$10.1B
$527K 0.56%
+30,000
New +$503K
GE icon
58
GE Aerospace
GE
$374B
$452K 0.48%
8,346
– –
EIGR
59
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$420K 0.45%
1,167
-1,833
-61% -$627K
IBM icon
60
CALL
IBM
IBM
$211B
$378K 0.4%
+2,615
New +$365K
NWL icon
61
Newell Brands
NWL
$2.38B
$305K 0.32%
15,000
– –
CTSO icon
62
Cytosorbents Corp
CTSO
$22.7M
$129K 0.14%
+10,000
New +$125K
CTLP
63
DELISTED
Cantaloupe
CTLP
$65K 0.07%
+9,055
New +$125K
AKBA icon
64
Akebia Therapeutics
AKBA
$354M
– –
-100,000
Closed -$998K
DKS icon
65
Dick's Sporting Goods
DKS
$17.5B
– –
-6,000
Closed -$212K
LKFT
66
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
– –
-9,000
Closed -$951K
IWM icon
67
PUT
iShares Russell 2000 ETF
IWM
$79.8B
– –
-40,000
Closed -$6.55M
MGNX icon
68
MacroGenics
MGNX
$235M
– –
-25,000
Closed -$516K
ONCE
69
PUT
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-12,000
Closed -$993K
1 2
3

Similar funds

EIM
Emmett Investment Management New York $131M AUM 25.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
LC
LTG Capital Newton, Massachusetts $131M AUM 19.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
OIM
Oder Investment Management Woodland Hills, California $130M AUM 25.54% 1-Year Est. Return
EPI
Eddie Patel Inc Chicago, Illinois $130M AUM

P.A.W. Capital's Q3 2018 Portfolio in Review

As of Q3 2018, P.A.W. Capital held 73 positions worth $94.2M, down 4.8% from $99M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

P.A.W. Capital withdrew a net $11.6M in Q3 2018, closing 7 positions and reducing 17 holdings. Its most notable exit was Akebia Therapeutics, an estimated $998K position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, P.A.W. Capital opened a new position in Palvella Therapeutics worth $1.4M.

  • P.A.W. Capital's largest Q3 2018 buy was Palvella Therapeutics: 3,125 shares worth $1.4M.
  • P.A.W. Capital added most to Cue Biopharma in Q3 2018, an estimated $482K increase.
  • P.A.W. Capital's biggest Q3 2018 reduction was Semler Scientific, cutting an estimated $1.69M.
  • P.A.W. Capital fully exited Akebia Therapeutics in Q3 2018, selling an estimated $998K.
  • P.A.W. Capital's ten largest holdings make up 41% of its $94.2M portfolio in Q3 2018.
  • P.A.W. Capital opened 9 new positions and closed 7 in Q3 2018.
  • P.A.W. Capital's portfolio value fell 4.8% quarter-over-quarter to $94.2M.

Based on P.A.W. Capital's 13F filing for Q3 2018, filed 24 Oct 2018.